Tinea Capitis - Pediatric Management

Key Points

• Tinea capitis requires oral antifungal therapy; topical creams alone do not eradicate infected hair shafts.
• Patchy alopecia, scale, broken hairs, and posterior cervical lymphadenopathy are common clues.
• Terbinafine is highly effective for many Trichophyton infections, while griseofulvin remains strong therapy for Microsporum.
• Antifungal shampoo reduces transmission but is adjunctive, not curative.
• A kerion is an inflammatory form of tinea capitis and should not routinely be incised and drained.
• Evaluate shared hair items, close contacts, and pets when epidemiologically relevant.

Algorithm

1. Recognize patchy alopecia with scale, broken hairs, black dots, or inflammatory kerion.
2. Obtain fungal testing when available or when diagnosis is uncertain.
3. Start systemic griseofulvin or terbinafine based on likely organism and patient factors.
4. Add selenium sulfide or ketoconazole shampoo to reduce shedding and transmission.
5. Assess household contacts and shared hair equipment; consider animal source.
6. Reassess after several weeks for hair regrowth and clinical response.
7. Investigate adherence, organism, and alternative diagnoses if treatment fails.

Clinical Synopsis & Reasoning

Tinea capitis occurs predominantly in children and presents with patchy alopecia, scale, broken hairs, black-dot alopecia, pruritus, posterior cervical or occipital lymphadenopathy, or an inflammatory boggy plaque called a kerion. Trichophyton species are common in the United States, while Microsporum remains important in many regions and after animal exposure. Seborrheic dermatitis, alopecia areata, traction alopecia, bacterial folliculitis, trichotillomania, and psoriasis can mimic the disorder.

Because the fungus invades the hair shaft and follicle, topical antifungal creams alone are inadequate. Diagnosis can be supported by potassium hydroxide examination, fungal culture, or molecular testing. Culture is useful when the presentation is atypical or treatment failure raises concern for the wrong organism. Wood lamp examination is organism-dependent and cannot rule out infection because common Trichophyton infections often do not fluoresce.

Kerion represents an intense inflammatory response rather than necessarily a bacterial abscess. It can be tender, boggy, pustular, and associated with lymphadenopathy. Incision and drainage is usually inappropriate and may worsen scarring. Secondary bacterial infection can occur but should be diagnosed clinically rather than presumed from pustules alone.

Treatment Strategy & Disposition

Use systemic antifungal therapy. Oral griseofulvin remains highly effective, especially for Microsporum, and is commonly used in children. Terbinafine is effective and often preferred for Trichophyton infection because treatment courses can be shorter. Exact dose and duration depend on formulation, body weight, organism, and local practice. Itraconazole or fluconazole are alternatives in selected patients.

Add selenium sulfide or ketoconazole shampoo several times weekly during early treatment to reduce surface spores and household transmission; shampoo alone will not cure the infection. Household members should be examined for scalp lesions, and shared combs, brushes, hats, helmets, and bedding should be cleaned or avoided. Pets should be evaluated when Microsporum or animal exposure is suspected.

Treat kerion with prompt systemic antifungal therapy. A short corticosteroid course is sometimes considered for severe inflammation, but routine use is not necessary and evidence for preventing scarring is limited. Do not drain a kerion as if it were a typical abscess. Reassess treatment failure for adherence, organism, dosing, and an alternative diagnosis.

Epidemiology / Risk Factors

• Tinea capitis primarily affects prepubertal children.
• Transmission occurs person-to-person, from infected animals, and through contaminated objects.
• Organism prevalence varies by geography and population.
• Crowding and shared hair-care equipment increase transmission risk.

Investigations

Therapy Snapshot

Pharmacology

Prognosis / Complications

• Appropriate systemic treatment usually cures infection and allows hair regrowth.
• Clinical scale and inflammation can improve before cultures become negative.
• Kerion can produce scarring alopecia if severe or treatment is delayed.
• Reinfection occurs when untreated contacts or contaminated hair items remain a source.

Patient Education / Counseling

• Explain that oral medicine is necessary even if the rash looks superficial.
• Use the prescribed shampoo as an adjunct and avoid sharing hair items.
• Complete the full systemic course because early cosmetic improvement does not guarantee eradication.
• Seek reassessment for worsening pain, fever, spreading bacterial infection, or failure of hair regrowth.

Notes

When a child has scalp scale plus hair loss, the hair itself is the key diagnostic tissue. Look for broken shafts, black dots, and short hairs rather than treating the condition as dandruff alone.

Kerion is a frequent source of unnecessary drainage procedures. Its boggy appearance reflects intense host inflammation around fungal infection. Systemic antifungal treatment is the essential intervention.

School attendance and household management should be individualized, but children do not need to be socially isolated for the entire multiweek systemic treatment course. The highest-yield prevention measures are avoiding shared combs, brushes, hats, helmets, and hair accessories and treating the infected child effectively. When fungal culture identifies Microsporum, ask specifically about cats, dogs, and other animal contact because veterinary evaluation may prevent reinfection. When a child has persistent alopecia despite clinical clearance, distinguish slow regrowth from true scarring. Smooth shiny scalp, loss of follicular openings, or persistent inflammatory plaques should prompt dermatology reassessment rather than simply extending antifungal therapy indefinitely.

References

1. American Academy of Dermatology clinical resources — Link
2. CDC Fungal Diseases Resources — Link